IP Library Assignment 068815/0189
Patent Assignment
Reel/Frame 068815/0189

Assignment of Assignor's Interest

Recorded: 2024-10-07 Pages: 11
Assignor
QUINCE THERAPEUTICS, INC.
Executed: 2023-01-27
Assignee
LIGHTHOUSE PHARMACEUTICALS, INC.
5214F DIAMOND HEIGHTS BOULEVARD, #3470, SAN FRANCISCO, CALIFORNIA, 94131
Covered Property (1)
Ketone Inhibitors of Lysine Gingipain
Application: 18/905,445 →
Publication: US 2025/0270162
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 7, 2024
From: KONRADI, ANDREI W.; GALEMMO, ROBERT A.; DOMINY, STEPHEN S.; LYNCH, CASEY C.
To: CORTEXYME, INC.
Reel/Frame 068814/0379 →
Assignment of Assignor's Interest Oct 7, 2024
From: GALEMMO, ROBERT A.
To: WUXI APPTEC (SHANGHAI) CO., LTD.
Reel/Frame 068814/0587 →
Assignment of Assignor's Interest Oct 7, 2024
From: WUXI APPTEC (SHANGHAI) CO., LTD.
To: WUXI APPTEC (HONG KONG) LIMITED
Reel/Frame 068814/0767 →
Assignment of Assignor's Interest Oct 7, 2024
From: WUXI APPTEC (HONG KONG) LIMITED
To: CORTEXYME, INC.
Reel/Frame 068814/0905 →
Change of Name Oct 7, 2024
From: CORTEXYME, INC.
To: QUINCE THERAPEUTICS, INC.
Reel/Frame 069114/0805 →